Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study
Publication

Publications

EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study

Title
EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study
Type
Article in International Scientific Journal
Year
2012
Authors
de Mello, RA
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Marques, DS
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Oliveira, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rodrigues, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Soares, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Azevedo, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Peixoto, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Santos, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pinto, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Amaro, T
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Queiroga, H
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Araujo, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Journal
Title: Tumor BiologyImported from Authenticus Search for Journal Publications
Vol. 33
Pages: 2061-2068
ISSN: 1010-4283
Publisher: SAGE
Other information
Authenticus ID: P-002-31M
Abstract (EN): Epidermal growth factor receptor (EGFR) mutations play a predictive role in advanced stages of non-small-cell lung cancer (NSCLC) patients. We conducted this study in order to assess EGFR status in a Portuguese population and its role in NSCLC patients' outcomes. Patients were submitted to EGFR assessment by high-resolution melting and/or direct sequencing. Kaplan-Meier curve was used to assess overall survival and progression-free survival (PFS). Two hundred forty eight out of 322 participants were assessed for EGFR status. Forty-two patients (16.9 %) presented EGFR-mutated status: one patient (2.4 %) presented exon 18; 21 patients (50 %), exon 19; one patient (2.4 %), exon 20; and 18 patients (45.2 %), exon 21 mutations, p < 0.001. PFS was not assessed (n.a.) for patient with exon 18 mutation, and for the other patients with mutations, it was 7 months (3.96-10.03) (exon 19), < 1 month (exon 20), and 7 months (0-14.2) (exon 21) (p = 0.027). Overall survival (OS) was 11 months (exon 18), 11 months (1-18) (exon 19), 1 month (exon 20), and 7.5 months (2-70) (exon 21) (p = n.a). This study suggests that the EGFR mutation is herein observed in a higher proportion than expected for a Caucasian population, and OS is a little less than that published in the literature.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer (2017)
Another Publication in an International Scientific Journal
Nuno Vale; Gouveia, MJ; Rinaldi, G; Santos, J; Santos, LL; Brindley, PJ; Correia da Costa, JMC
Restoring TGF beta 1 pathway-related microRNAs: possible impact in metastatic prostate cancer development (2014)
Another Publication in an International Scientific Journal
Santos, JI; Teixeira, AL; Dias, F; Gomes, M; Nogueira, A; Assis, J; Rui Medeiros
Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer (2014)
Article in International Scientific Journal
Hugo Sousa; Sara Oliveira; Alexandra M Santos; Raquel Catarino; Jose Moutinho; Rui Medeiros
STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment (2016)
Article in International Scientific Journal
Silva, LS; Goncalves, LG; Silva, F; Domingues, G; Maximo, V; Ferreira, J; Lam, EWF; Dias, S; Felix, A; Serpa, J

See all (13)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-22 at 06:37:37 | Privacy Policy | Personal Data Protection Policy | Whistleblowing